Asia Pacific Cell-based Assays Market Size & Outlook
Asia Pacific cell-based assays market, 2018-2030 (US$M)
Related Markets
Asia Pacific cell-based assays market highlights
- The Asia Pacific cell-based assays market generated a revenue of USD 3,190.2 million in 2024.
- The market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
- In terms of segment, assay kits was the largest revenue generating products & services in 2024.
- Reagents is the most lucrative products & services segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 3,190.2 million |
| Market revenue in 2030 | USD 5,605.3 million |
| Growth rate | 9.8% (CAGR from 2024 to 2030) |
| Largest segment | Assay kits |
| Fastest growing segment | Reagents |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Microplates, Probes & Labels, Instruments & Software, Assay Kits, Cell Lines |
| Key market players worldwide | BD, Bio-Rad Laboratories Inc, Corning Inc, Charles River Laboratories International Inc, Danaher Corp, Roche Holding AG, Lonza Group Ltd, Merck KGaA, Thermo Fisher Scientific Inc, Promega |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.5% of the global cell-based assays market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,605.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell-based Assays Market Scope
Cell-based Assays Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific cell-based assays market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell-based assays market will help companies and investors design strategic landscapes.
Assay kits was the largest segment with a revenue share of 37.65% in 2024. Horizon Databook has segmented the Asia Pacific cell-based assays market based on reagents, microplates, probes & labels, instruments & software, assay kits, cell lines covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific Cell-based Assays Products & Services Outlook (Revenue, USD Million, 2018-2030)
- Reagents
- Microplates
- Probes & Labels
- Instruments & Software
- Assay Kits
- Cell Growth Assays
- Reporter Gene Assays
- Cell Death Assays
- Second Messenger Assays
- Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Immortalized Cell Lines
- Asia Pacific Cell-based Assays Application Outlook (Revenue, USD Million, 2018-2030)
- Basic Research
- Drug Discovery
- Other Applications
- Asia Pacific Cell-based Assays End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Reasons to subscribe to Asia Pacific cell-based assays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific cell-based assays market databook
-
Our clientele includes a mix of cell-based assays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cell-based assays market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cell-based assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific cell-based assays market size, by country, 2018-2030 (US$M)
Asia Pacific Cell-based Assays Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
